EQ Equillium
- 0.7130
- -0.0725-9.23%
- 0.7080
- -0.0050-0.70%
Equillium News
Equillium to Be Included in the Russell Microcap Index
LA JOLLA, Calif.--(BUSINESS WIRE)--$EQ--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disord
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $5
H.C. Wainwright analyst Ram Selvaraju maintains $Equillium(EQ.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 36.8% and a tot
Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings
U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 200 points on Tuesday.The Dow traded up 0.53% to 38,774.55 while the NASDAQ rose 0.29% to 16,877.87. The S&P 500
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Core & Main Inc (NYSE:CNM) fell sharply during Tuesday's session after the company reported mixed first-quarter financial results.Core & Main posted quarterly earnings of 49 cents per share,
Nano-Cap Equillium Shares Fall After Patchy Hair Loss Study Data
Equillium Inc. (NASDAQ:EQ) announced Tuesday topline data from its Phase 2, single-dose, proof-of-concept (PoC) study of EQ101 in adult patients with alopecia areata.Alopecia is an autoimmune disease
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersConcord Medical Services (NYSE:CCM) shares moved upwards by 51.9% to $1.2 during Tuesday's regular session. The market value of their outstanding shares is at $52.1 million. Annexon (NASDAQ:ANN
Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 50 points on Tuesday.The Dow traded down 0.14% to 38,516.73 while the NASDAQ fell 0.38% to 16,764.41. The S&P 50
US Stocks Lower; Donaldson Earnings Beat Views
U.S. stocks traded lower this morning, with the Dow Jones falling more than 70 points on Tuesday.Following the market opening Tuesday, the Dow traded down 0.20% to 38,493.85 while the NASDAQ fell 0.22
Equillium Posts Early Mid-stage Data for Hair Loss Therapy
Express News | Equillium Shares Are Trading Higher After the Company Announced Topline Data From Its Phase 2 Study of EQ101 in Alopecia Areata
Express News | Equillium Inc: EQ101 Was Well Tolerated in Subjects With Alopecia Areata With No Serious Adverse Events Reported
Express News | Equillium Announces Positive Topline Data From Phase 2 Study of EQ101 in Alopecia Areata
Equillium to Present at the Jefferies Global Healthcare Conference
LA JOLLA, Calif.--(BUSINESS WIRE)--$EQ--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disord
Express News | HC Wainwright & Co. Reiterates Buy on Equillium, Maintains $5 Price Target
Equillium Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 223.62% HC Wainwright & Co. → $5 Reiterates Buy → Buy 04/02/2024 223.62% HC Wainwright & Co. $4
Buy Rating Affirmed for Equillium on Milestones and Financial Prospects
Express News | Equillium Surpasses Interim Enrollment Target For Phase 3 EQUATOR Study Of Itolizumab II Acute Graft-Versus-Host Disease
Express News | Equillium Inc - Delivery of Interim Data Review to Ono Pharmaceutical Co. Ltd. (Ono) Expected During Q3 Will Trigger Ono's Option Exercise Period
Express News | Equillium Announces Interim Enrollment Achieved in Phase 3 Equator Study of Itolizumab in Acute Graft-Versus-Host Disease
Analysis
Price Target
No Data
